SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 273 filers reported holding SAGE THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 0.75 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $12,536,000 | -76.1% | 436,477 | +16.8% | 1.03% | -33.5% |
| Q3 2019 | $52,444,000 | +94.3% | 373,828 | +120.3% | 1.55% | +159.9% |
| Q1 2019 | $26,987,000 | -44.3% | 169,676 | -66.5% | 0.60% | -53.7% |
| Q4 2018 | $48,448,000 | +807.1% | 505,776 | +573.0% | 1.29% | +860.4% |
| Q1 2017 | $5,341,000 | -15.9% | 75,158 | -62.1% | 0.13% | -31.6% |
| Q1 2016 | $6,350,000 | +166.6% | 198,058 | +384.8% | 0.20% | +172.2% |
| Q4 2015 | $2,382,000 | – | 40,850 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 179,200 | $29,516,000 | 16.65% |
| TRV GP II, LLC | 547,916 | $90,247,000 | 16.25% |
| Opus Point Partners Management, LLC | 71,000 | $11,694,000 | 10.12% |
| Casdin Capital, LLC | 250,000 | $41,178,000 | 10.03% |
| RA Capital Management | 455,173 | $74,972,000 | 6.27% |
| Crawford Lake Capital Management, LLC | 154,278 | $25,411,000 | 6.00% |
| Palo Alto Investors LP | 810,806 | $133,548,000 | 5.75% |
| GREAT POINT PARTNERS LLC | 200,000 | $32,942,000 | 5.62% |
| BB BIOTECH AG | 1,042,439 | $171,700,000 | 4.84% |
| Crawford Lake Capital Management, LLC | 92,300 | $15,203,000 | 3.59% |